These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30535006)

  • 21. Nivolumab-induced acute demyelinating polyradiculoneuropathy mimicking Guillain-Barré syndrome.
    Nukui T; Nakayama Y; Yamamoto M; Taguchi Y; Dougu N; Konishi H; Hayashi T; Nakatsuji Y
    J Neurol Sci; 2018 Jul; 390():115-116. PubMed ID: 29801870
    [No Abstract]   [Full Text] [Related]  

  • 22. Nivolumab-associated Stevens-Johnson syndrome in a patient with lung cancer.
    Gracia-Cazaña T; Padgett E; Calderero V; Oncins R
    Dermatol Online J; 2021 Mar; 27(3):. PubMed ID: 33865285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nivolumab-induced myocarditis complicated by complete atrioventricular block in a patient with metastatic non-small cell lung cancer.
    Tan JL; Mugwagwa AN; Cieslik L; Joshi R
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31300602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous hematoma of the thigh associated with antiproteinase-3 antibody in a patient with metastatic squamous cell carcinoma treated with nivolumab.
    Keung YK; Hu EH
    J Oncol Pharm Pract; 2019 Jul; 25(5):1261-1264. PubMed ID: 29984627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of mild drug-induced sclerosing cholangitis after discontinuation of nivolumab.
    Noda-Narita S; Mizuno S; Noguchi S; Watanabe K; Nakai Y; Koike K; Kage H; Nagase T
    Eur J Cancer; 2019 Jan; 107():93-96. PubMed ID: 30554074
    [No Abstract]   [Full Text] [Related]  

  • 26. Eczematous reactions mimicking psoriasiform dermatitis induced by nivolumab for advanced lung cancer.
    Tanaka M; Hoashi T; Ichiyama S; Noro R; Seike M; Kubota K; Gemma A; Funasaka Y; Saeki H
    Australas J Dermatol; 2019 Feb; 60(1):e67-e68. PubMed ID: 29896926
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis: hypersensitivity myocarditis, or something else.
    Kounis NG; Mplani V
    Invest New Drugs; 2024 Aug; 42(4):478-479. PubMed ID: 39017983
    [No Abstract]   [Full Text] [Related]  

  • 28. Nivolumab-Associated Guillain-Barre Syndrome in a Patient With Non-Small-Cell Lung Cancer.
    Thapa B; Khalid S; Vakili R; Ui J; Misbah S
    Am J Ther; 2018; 25(6):e761-e763. PubMed ID: 29889678
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute demyelinating polyneuropathy induced by nivolumab.
    Fukumoto Y; Kuwahara M; Kawai S; Nakahama K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):435-437. PubMed ID: 28844069
    [No Abstract]   [Full Text] [Related]  

  • 30. Immune-related intestinal pseudo-obstruction associated with nivolumab treatment in a lung cancer patient.
    Fragulidis G; Pantiora E; Michalaki V; Kontis E; Primetis E; Vezakis A; Polydorou A
    J Oncol Pharm Pract; 2019 Mar; 25(2):487-491. PubMed ID: 29067858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nivolumab-induced myositis: A case report and a literature review.
    Bourgeois-Vionnet J; Joubert B; Bernard E; Sia MA; Pante V; Fabien N; Honnorat J; Streichenberger N
    J Neurol Sci; 2018 Apr; 387():51-53. PubMed ID: 29571871
    [No Abstract]   [Full Text] [Related]  

  • 32. Widespread Nivolumab-induced Enteropathy in a Long Responder Non-Small-cell Lung Cancer Patient.
    Facchinetti F; Gnetti L; Caruana P; Fornaroli F; Luigi de'Angelis G; Sabato M; Ferri L; Cosenza A; Bordi P; Tiseo M
    Clin Lung Cancer; 2018 Sep; 19(5):e591-e596. PubMed ID: 29801705
    [No Abstract]   [Full Text] [Related]  

  • 33. Stevens-Johnson syndrome associated with radiation recall dermatitis in a patient treated with nivolumab.
    Rouyer L; Bursztejn AC; Charbit L; Schmutz JL; Moawad S
    Eur J Dermatol; 2018 Jun; 28(3):380-381. PubMed ID: 29952288
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune checkpoint inhibitor induced large vessel vasculitis.
    Henderson D; Eslamian G; Poon D; Crabb S; Jones R; Sankey P; Kularatne B; Linch M; Josephs D
    BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32430351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring.
    Katsume Y; Isawa T; Toi Y; Fukuda R; Kondo Y; Sugawara S; Ootomo T
    Intern Med; 2018 Nov; 57(21):3157-3162. PubMed ID: 29877257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New biomarker-based strategy screens for myocarditis after immune checkpoint inhibitor treatment.
    Nierengarten MB
    Cancer; 2023 May; 129(9):1304. PubMed ID: 37029508
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.
    Koda R; Watanabe H; Tsuchida M; Iino N; Suzuki K; Hasegawa G; Imai N; Narita I
    BMC Nephrol; 2018 Feb; 19(1):48. PubMed ID: 29486725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asymptomatic Myocarditis with Mild Cardiac Marker Elevation Following Nivolumab-Induced Myositis.
    Shindo A; Yamasaki M; Uchino K; Yamasaki M
    Int Heart J; 2022; 63(1):180-183. PubMed ID: 35095069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral Anterior Uveitis Associated with Nivolumab Therapy.
    Karlin J; Gentzler R; Golen J
    Ocul Immunol Inflamm; 2018; 26(2):283-285. PubMed ID: 27599197
    [No Abstract]   [Full Text] [Related]  

  • 40. Bicytopenia in Primary Lung Melanoma Treated with Nivolumab.
    Takahashi A; Kubo A; Mizuno S; Kasai K; Asai N; Yonezawa T; Kosaka K; Nishimura M; Tanaka H; Yokoe N; Tsuzuki T; Takami A; Yamaguchi E
    Intern Med; 2019 Mar; 58(6):827-831. PubMed ID: 30449777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.